Evidence map›Paper›PMID 29234543›Full record

ArticleArab journal of urology2017

A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence.

Kirill V Kosilov, Sergay A Loparev, Irina G Kuzina, Olga V Shakirova, Yuliya I Gainullina, Liliya V Kosilova, Alexandra S Prokofyeva

Abstract read
In one paragraph

Article in Arab journal of urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kirill V KosilovDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Primorsky Region, Russian Federation.
Sergay A LoparevDepartment of Urology, City Polyclinic № 3, Vladivostok, Russian Federation.
Irina G KuzinaDepartment of Social Science, Far Eastern Federal University, Vladivostok, Primorsky Region, Russian Federation.
Olga V ShakirovaDepartment of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Primorsky Region, Russian Federation.
Yuliya I GainullinaDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Primorsky Region, Russian Federation.
Liliya V KosilovaDepartment of Functional Methods of Examination, Med. Association № 2 of Vladivostok City, Vladivostok, Russian Federation.
Alexandra S ProkofyevaDepartment Social Science, Far Eastern Federal University, Vladivostok, Primorsky Region, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ABSTRACT

objectiveTo evaluate the validity of the Medication Adherence Self-Report Inventory (MASRI) questionnaire in determining antimuscarinic drugs adherence in patients with urinary incontinence (UI). PATIENTS AND

methodsIn all, 629 patients [355 (56.4%) women and 274 (43.6%) men], aged 18-65 years, were included. All patients were prescribed antimuscarinic drugs and treatment adherence was tested at the start, and after 4, 8 and 12 weeks using the MASRI. The standard of external monitoring was the Brief Medication Questionnaire (BMQ) and visual count of the remaining pills. The functional status of the lower urinary tract was tested using voiding diaries and uroflowmetry.

resultsThe correlation between indicators of adherence according to the MASRI and screen mode of the BMQ was

conclusionThe MASRI questionnaire is highly constructive, competitive, has discriminant validity, and is suitable for self-assessment of treatment adherence in patients with UI taking antimuscarinics. Using the MASRI is less costly and faster compared with other assessment tools.

Indexed as

AdherenceAntimuscarinicAUC, area under the curveBMQ, Brief Medication QuestionnaireICIQ-SF, International Consultation on Incontinence Questionnaire-Short FormLUT, lower urinary tractMASRI, Medication Adherence Self-Report Inventory(M)(S)(U)UI, (mixed) (stress) (urgency) urinary incontinenceOAB, overactive bladderQuestionnaireROC, Receiver operating characteristicSelf-evaluationUrinary incontinence

Identifiers

PMID29234543
PMCPMC5717450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.